Retinoblastoma vascular perfusion and intra-arterial chemotherapy cycle requirements.
Li-Anne S LimLauren A DalvinDavid Ancona-LezamaMichael D YuPascal JabbourCarol L ShieldsPublished in: Clinical & experimental ophthalmology (2019)
FA demonstrating partial retinoblastoma tumour perfusion is associated with fewer IAC cycle requirements for secondary but not primary IAC. FA might be useful in judging anticipated treatment cycles of retinoblastoma managed with primary or secondary IAC.